Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies

MLA

Alberto Visioli, et al. “Different States of Stemness of Glioblastoma Stem Cells Sustain Glioblastoma Subtypes Indicating Novel Clinical Biomarkers and High-Efficacy Customized Therapies.” Journal of Experimental & Clinical Cancer Research, vol. 42, no. 1, Sept. 2023, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s13046-023-02811-0.

APA

Alberto Visioli, Nadia Trivieri, Gandino Mencarelli, Fabrizio Giani, Massimiliano Copetti, Orazio Palumbo, Riccardo Pracella, Maria Grazia Cariglia, Chiara Barile, Luigi Mischitelli, Amata Amy Soriano, Pietro Palumbo, Federico Legnani, Francesco DiMeco, Leonardo Gorgoglione, Graziano Pesole, Angelo L. Vescovi, & Elena Binda. (2023). Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies. Journal of Experimental & Clinical Cancer Research, 42(1), 1–17. https://doi.org/10.1186/s13046-023-02811-0

Chicago

Alberto Visioli, Nadia Trivieri, Gandino Mencarelli, Fabrizio Giani, Massimiliano Copetti, Orazio Palumbo, Riccardo Pracella, et al. 2023. “Different States of Stemness of Glioblastoma Stem Cells Sustain Glioblastoma Subtypes Indicating Novel Clinical Biomarkers and High-Efficacy Customized Therapies.” Journal of Experimental & Clinical Cancer Research 42 (1): 1–17. doi:10.1186/s13046-023-02811-0.